BrokerLens

Glenmark Life Sciences Limited IPO (GLS)

Status
Listed
Security type
Mainboard
Price band
Rs.695 to Rs.720
Final issue price
Rs 720
Issue size
Not disclosed
Bidding opens
27 July 2021
Bidding closes
29 July 2021
Listing date
6 August 2021

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Glenmark Life Sciences Limited IPO?

The Glenmark Life Sciences Limited IPO price band is Rs.695 to Rs.720 per share.

When does the Glenmark Life Sciences Limited IPO open and close?

Bidding opens 27 July 2021 and closes 29 July 2021.

Is the Glenmark Life Sciences Limited IPO a mainboard or SME issue?

Glenmark Life Sciences Limited is a mainboard IPO, listing on NSE's main board.

When did the Glenmark Life Sciences Limited IPO list?

Glenmark Life Sciences Limited listed on 6 August 2021.

Does this page show the grey market premium (GMP) for Glenmark Life Sciences Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Glenmark Life Sciences Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.